Graft survival rate of renal transplantation: A single center experience, (1999-2009)

Iranian Red Crescent Medical Journal

Volumn 13, Issue 6, 2011, Pages

  Almasi Hashiani, A ^a   Rajaeefard, A R ^b   Hassanzade, J ^b   Salahi, H ^c   Nikeghbalian, S ^c   Janghorban, P ^c   Malek Hosseini, S A ^c  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cox regression model; Graft survival; Iran; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE;

EID: 79959279146     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abbaszadeh S, Nourbala MH, Taheri S, Ashraf A, Einollahi B. Renal transplantation from deceased donor in Iran. Saudi J Kidney Dis Transpl 2008;19:664-668. [18580034]
2. Haghighi AN, Broumand B, D'Amico M, Locatelli F, Ritz E. The epidemiology of end- stage renal disease in Iran in an international perspective. Nephrol Dial Transplant 2002;17:28-32. [11773458] [doi:10.1093/ndt/17.1.28]
3. Abboud O. Incidence, prevalence and treatment of End Stage Renal Disease in the Middle East. Ethn Dis 2006;16:S2-2-4. [16774000]
4. Mahdavi-Mazdeh M, Heidary-Rouchi A, Aghighi M, Rajolani H. Organ and tissue transplantation in Iran. Saudi J Kidney Dis Transpl 2008;19:127-131. [18087142]
5. Mahdavi-Mazdeh M, Heidary Rouchi A, Norouzi S, Aghighi M, Rajolani H, Ahrabi S. Renal Replacement therapy in Iran. Urol J 2007;4:66-70. [17701924]
6. Schena FP. Epidemiology of End Stage Renal Disease: International comparisons of Renal Replacement therapy. Kidney International 2000; 57:S39-S45. [doi:10.1046/j.1523-1755.2000.07407.x]
7. Hariharan S, Johnson CP, Barbara BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605-612. [10699159] [doi:10.1056/NEJM200003023420901]
8. Cacho DT, Cusí LI, Piqué AA, Villar PB, Reyes LI, Alvarez-Vijande García R, Salinas FO, del Pozo RG. Elderly donor kidney transplant: factors involved in graft survival. Transplant Proc 2005;37:3690-3692. [16386507] [doi:10.1016/j.transproceed.2005.10.071]
9. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, Leichtman AB, Kaplan B. Effect of waiting time on renal transplant out come. Kidney Int 2000;58:1311-1317. [10972695] [doi:10.1046/j.1523-1755.2000.00287.x]
10. Shrestha BM, Haylor JL. Factors influencing long term outcome following renal transplantation: A review. J Nepal Med Assoc 2007; 46:136-142. [18274571]
11. Briganti EM, Wolfe R, Russ GR, Eris JM, Walker RG, McNeil JJ. Graft loss following renal transplantation in Australia: Is there a center effect? Nephrol Dial Transplant 2002;17: 1099-1104. [12032203] [doi:10.1093/ndt/17.6.1099]
12. Orsenigo E, Socci C, Carlucci M, Zuber V, Fiorina P, Gavazzi F, Secchi A, Di Carlo V, Staudacher C. Multivariate analysis of factors affecting patient and graft survival after renal transplant. Transplant Proc 2005;37:2461-2463. [16182709] [doi: 10.1016/j.transproceed.2005.06.099]
13. Courtney AE, MCnamee PT, Maxwell AP. The evolution of renal transplantation in clinical practice: for better, for worse? QJM 2008; 101:967-978. [18927195] [doi:10.1093/qjmed/hcn136]
14. Kaplan B, Schold JD, Meier-Kriesche HU. Long term graft survival with Neoral and Tacrolimus: A Paired Kidney Analysis. J Am Soc Nephrol 2003;14:2980-2984. [14569110] [doi:10.1097/01.ASN.0000095250.92361.D5]
15. Pugliese O, Quintieri F, Mattucci DA, Venettoni S, Taioli E, Costa AN. Kidney graft survival in Italy and factors influencing it. Prog Transplant 2005;15:385-391. [16477822]
16. Bakr MA, Ghoneim MA. Living donor renal transplantation, 1976-2003: The Mansoura Experience. Saudi J Kidney Dis Transpl 2005; 16:573-583. [18202512]
17. Feyssa E, Jones-Burton C, Ellison G, Philosophe B, Howell C. Racial/ethnic disparity in kidney transplantation outcomes: influence of donor and recipient characteristics. J Natl Med Assoc 2009;101:111-115. [19378626]
18. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Hepatitis C antibody status and outcome in renal transplant recipients. Transplantation 2001;72:241-244. [11477346] [doi:10.1097/00007890-200107270-00013]
19. Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M. Pretransplantation Hepatitis C virus infection:a predictor of proteinuria after renal transplantation. Transplantation 1998;65:741-744. [9521213] [doi:10.1097/00007890-199803150-00024]
20. Shahbazian H, Hajiani E, Ehsanpour A. Patient and graft survival oh allograft recipients with minimal hepatitis C virus infection a case control study. Urol J 2008;5:178-173. [18825625]
21. Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Khatami MR, Nourbala MH, Pourfarziani V, Alavian SM. Pre-transplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 2003;18:836-840. [12795757] [doi:10.1046/j.1440-1746.2003.03063.x]
22. Mitwalli AH, Alam A, Al-Wakeel J, Al Suwaida K, Tarif N, Schaar TA, Al Adbha B, Hammad D. Effect of Chronic Viral Hepatitis on Graft Survival in Saudi Renal Transplant Patients. Nephron Clin Pract 2006;102:c72-c80. [16244496] [doi: 10.1159/000089090]
23. El-Husseini AA, Foda MA, Shokeir AA, Shehab El-Din AB, Sobh MA, Ghoneim MA. Determinants of graft survival in paediatric and adolescent live donor kidney transplant recipients: A single center experience. Pediatr Transplant 2005;9:763-769. [16269048] [doi:10.1111/j.1399-3046.2005.00376.x]
24. El-Husseini AA, Mohamed AF, Mohamed AB, Shokeir AA, Sobh MA, Ghoneim MA. Paediatric livedonor kidney transplantation in Mansoura Urology& Nephrology Center: a 28-year perspective. Pediatr Nephrol 2006;21:1464-1470. [16791608] [doi:10.1007/s00467-006-0150-2]
25. Resende L, Guerra J, Santana A, Mil-Homens C, Abreu F, da Costa AG. Influence of Dialysis Duration and Modality on Kidney Transplant Outcomes. Transplant Proc 2009; 41:837-839. [19376365] [doi:10.1016/j.transproceed.2009.01.063]
26. Mange KC, Joffe MM, Feldman HI. Effect of the use or non-use of long term dialysis on the subsequent survival of renal transplantation from living donor. N Engl J Med 2001; 344:726-731. [11236776] [doi:10.1056/NEJM200103083441004]
27. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Gritsch HA, Fox-Hawranko L, Doyle HR, Johnson LB, Fenton R, Painter L, Keefer-Wolf K, Redman C, McCauley J, Fung JJ, Hakala TR, Starzl TE, Simmons RL. Reducing the length of stay after kidney transplantation - the intensive outpatient unit. Clin Transplant 1998;12:482-485. [9787961]
28. Lin SJ, Koford JK, Baird BC, Habib AN, Reznik I, Chelamcharla M, Shihab FS, Goldfarb-Rumyantzev AS. The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival. Clin Transplant 2006:20:245-252. [16640534] [doi: 10.1111/j.1399-0012.2005.00476.x]
29. Opelz G. Immunosuppression with FK506 does not improve kidney graft survival. Transplant Proc 1999;31:147-148. [doi:10.1016/S0041-1345(98)01940-X]
30. Rayhill SC, D'Alessandro AM, Odorico JS, Knechtle SJ, Pirsch JD, Heisey DM, Kirk AD, Van der Werf W, Sollinger HW. Simultaneous Pancreas-Kidney Transplantation and Living Related Donor Renal Transplantation in Patients With Diabetes: Is There a Difference in Survival? Ann Surg 2000;231:417-423. [10714635] [doi:10.1097/00000658-200003000-00015]